Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Ten Kate

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinningLuigi Lorenzini, Mario Tranfa, Leonard Pieperhoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
The Lancet. Neurology|July 20, 2017
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkersGiovanni B Frisoni, Marina Boccardi, Frederik Barkhof, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Biomedicines|November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery CohortJin Xu, Rebecca Green, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinningLuigi Lorenzini, Mario Tranfa, Leonard Pieperhoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
The Lancet. Neurology|July 20, 2017
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkersGiovanni B Frisoni, Marina Boccardi, Frederik Barkhof, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Biomedicines|November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery CohortJin Xu, Rebecca Green, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Pageof 8